4510 Executive Drive
BIOCOM is the largest regional life science association in the world, representing more than 550 member companies in Southern California across all major life science sectors, including biotechnology, pharmaceutical, diagnostic, medical device, connected health and biorenewables. The association focuses on initiatives that positively influence the region’s life science community in the development and delivery of innovative products that improve health and quality of life. BIOCOM provides a tremendous range of initiatives and programs in public policy, capital access, group savings, professional network building and talent development. For more information on BIOCOM or the Southern California life science community, please click around our site (www.biocom.org) or call (858) 455-0300.
• Joseph D. Panetta, President and CEO
• Jennifer Landress, Sr. VP and Chief Operating Officer
• Rick Fultz, VP Business Development BIOCOM, Managing Director BIOCOM Purchasing Group
139 articles with Biocom
Judy Chou, Ph.D., senior vice president and global head of biotech/Berkeley site head, Bayer, Emad Fareed, partner at KPMG, and Bob Ramos, partner at Procopio, to its board of directors.
California is well-known for its position in the biotech and pharma industry, with two world-class hubs in the Bay Area and the San Diego region. However, a new survey reveals the state is actually home to three significant hubs.
Biocom, the association representing the California life science industry, today announced that it has added Matt Abernethy, chief financial officer of Neurocrine Biosciences, and Sabrina Martucci Johnson, president and chief executive officer of Daré Biosciences, to its board of directors.
BioLA was founded in 2018 to ensure Los Angeles has a collaborative, well-coalesced ecosystem that encompasses all aspects of the Southern California life sciences cluster.
California’s life science sector is a major player in the state’s job creation and economic development. In 2016, life science companies in California employed more than 360,000 professionals.
Biotech companies need more than just researchers to ensure success. The most recent 2018 Talent Report issued by Biocom shows that 88 percent of California life science companies are planning on hiring over the next 12 months.
Biocom, the association representing the life science industry of California, and The CO Network, a culture technology company, today announced that they are hosting the 3rd Annual Big Data Summit at The Alexandria at Torrey Pines on Tuesday, November 6, 2018 from 8:15 am to 7:00 pm.
Biocom, the association representing the life science industry of California, today applauded the introduction of H.R. 6801, the Rare Disease (RaD) Fund Act by U.S. Representatives Juan Vargas (D-CA), Scott Peters (D-CA) and Tom Rooney (R-FL).
Biocom, the association representing the California life science industry, today announced the formation of a San Francisco Bay Area advisory board, as well as the grand opening of its Bay Area office.
Biocom, the association representing the California life science industry, today announced the endorsement of Nathan Fletcher for the San Diego County Board of Supervisors District 4 seat.
Biocom, the association representing the California life science industry, today announced the appointment of two new members to its board of directors: Deanne Calvert, J.D., head of state government relations for Sanofi US, and Ranjeet Banerjee, worldwide president of Medication Management Solutions for BD, a leading global medical technology company.
Biocom issued the following statement regarding the passage of H.R. 184, the Protect Medical Innovation Act, in the U.S. House of Representatives by a 283-132 vote.
Biocom announced the appointment of Taylor Crouch, Michael Farrington, Marc T. Morley and Peter Silvester to its board.
Life Science Association Brings Decade of Experience to Los Angeles’ Largest Science Festival
Biocom concluded its Regenerative Medicine Advocacy Fly-In to Washington, D.C. yesterday, the culmination of almost a year of efforts to elevate the voice of California’s regenerative medicine community.
Biocom, the association representing the California life science industry, today announced the appointment of four new members to its board.
Biocom, the association representing the life science industry of California, issued the following statement regarding the two-year suspension of the medical device tax included in H.R. 195, legislation to end a government shutdown.
Biocom issued the following statement regarding passage of H.R.1, the “Tax Cuts and Jobs Act” in the U.S. House of Representatives and Senate today.
Biocom, the association representing the life science industry of California, submitted the following statement regarding H.R. 4617, legislation introduced in the House of Representatives this week to extend the suspension of the medical device excise tax until 2022.
Biocom Urges Senate Committee to Improve Orphan Drug Tax Credit Provision, Eliminate Provision Taxing Stock Options
The statement can be attributed to Joe Panetta, Biocom’s president and CEO.